A recap of the top headlines from Contemporary OB/GYN in September 2026, spanning ACOG's respiratory vaccine guidance to the launch of the Missed & Dismissed podcast.
News|Articles|September 21, 2026
Contemporary OB/GYN Weekly Review: Testosterone evidence, ECV counseling, and more
Author(s)Joshua Fitch, Senior Editor
Fact checked by: Benjamin P. Saylor
Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
Advertisement
Advertisement
Thank you for visiting the Contemporary OB/GYN website. Take a look at some of our top stories from the past week (Monday, September 14, to Friday, September 18, 2026) and click on each link to read and watch anything you may have missed.
Related to this article
A recap of Contemporary OB/GYN's top FDA and regulatory news from September 2026.
ACOG issued its most comprehensive menopause guidance, grading treatments for VMS, sleep, and mood symptoms.
Soma Mandal, MD, is launching “Mind, Body, & the Pause: the Perimenopause and Beyond Series” on Contemporary OB/GYN, featuring specialists from across Hackensack Meridian Health.
Psychotherapy addresses fear and anxiety that can blunt hormone and pelvic floor therapy in menopause care, according to Sheryl Kingsberg, PhD.
Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
Pritelivir healed all HSV lesions by day 28 in 63% of immunocompromised adults vs 34% with comparators.
Fezolinetant (Veozah) was linked to objective and patient-reported sleep gains in OPTION-VMS, with no new safety signals observed.
Advertisement
Advertisement